IA
VRTX icon

IFG Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

IFG Advisory’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,941
Closed -$880K – 864
2025
Q4 		$880K Hold
1,941
– – 0.04% 393
2025
Q3 		$760K Sell
1,941
-44
-2% -$18.4K 0.03% 411
2025
Q2 		$884K Buy
1,985
+3
+0.2% +$1.38K 0.04% 378
2025
Q1 		$961K Hold
1,982
– – 0.05% 333
2024
Q4 		$798K Buy
+1,982
New +$919K 0.05% 332
2024
Q3 		– Sell
-2,181
Closed -$1.02M – 620
2024
Q2 		$1.02M Buy
+2,181
New +$947K 0.07% 273
2024
Q1 		– Sell
-2,319
Closed -$944K – 583
2023
Q4 		$944K Buy
2,319
+14
+0.6% +$5.17K 0.07% 252
2023
Q3 		$802K Buy
+2,305
New +$806K 0.07% 257
2023
Q2 		– Sell
-2,342
Closed -$738K – 503
2023
Q1 		$738K Sell
2,342
-20
-0.8% -$6K 0.07% 255
2022
Q4 		$682K Buy
2,362
+29
+1% +$8.84K 0.07% 265
2022
Q3 		$675K Buy
+2,333
New +$671K 0.06% 274
2019
Q3 		– Sell
-2,264
Closed -$415K – 452
2019
Q2 		$415K Buy
2,264
+47
+2% +$8.22K 0.07% 226
2019
Q1 		$407K Sell
2,217
-158
-7% -$29.2K 0.08% 221
2018
Q4 		$393K Buy
2,375
+2
+0.1% +$347 0.09% 210
2018
Q3 		$457K Sell
2,373
-12
-0.5% -$2.14K 0.09% 226
2018
Q2 		$405K Buy
2,385
+142
+6% +$22K 0.08% 228
2018
Q1 		$365K Sell
2,243
-5
-0.2% -$817 0.08% 233
2017
Q4 		$336K Buy
+2,248
New +$333K 0.08% 243

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

IFG Advisory's VRTX Position: Q1 2026 in Review

IFG Advisory sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 1,941 shares — an estimated $880K sold.

IFG Advisory first reported a position in VRTX in Q4 2017 and held it in 18 quarters. The position peaked at $1.02M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • IFG Advisory reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • IFG Advisory sold 1,941 Vertex Pharmaceuticals shares in Q1 2026, an estimated $880K.
  • IFG Advisory first reported a position in Vertex Pharmaceuticals in Q4 2017 and held it in 18 quarters.
  • IFG Advisory's Vertex Pharmaceuticals position peaked at $1.02M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.